Economy May 03 Biogen to replace CEO after Alzheimer’s drug flops Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers.
Economy Apr 28 FDA issues plan to ban menthol flavor in cigarettes, cigars Menthol is the only cigarette flavor that was not banned under the 2009 law that gave the FDA authority over tobacco products. The Biden administration has been under pressure from African American groups and health advocates to eliminate the flavor.
Politics Apr 22 Federal officials’ plan to ban menthol cigarettes prompts late lobbying blitz Dozens of interest groups have met with White House staffers to try to influence a long-awaited plan to ban menthol cigarettes.
Health Mar 30 FDA panel narrowly rejects experimental ALS drug Wednesday's vote by the Food and Drug Administration expert panel is a potential setback for patient groups who have lobbied for the medication's approval for ALS for more than a year.
Health Mar 29 FDA approves second booster for people 50 and older U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.
Health Feb 18 FDA warns parents not to use recalled infant formulas tied to infections U.S. health officials warned parents not to use infant formulas manufactured at an Abbott plant that they've linked to bacterial contamination.
Politics Feb 15 Senate confirms Biden’s FDA pick after narrow vote The Senate has narrowly confirmed President Joe Biden's pick to lead the Food and Drug Administration, filling a position that had been open for more than a year.
Health Feb 11 More data needed on Pfizer’s COVID-19 vaccine for kids under 5, FDA says The Food and Drug Administration had urged Pfizer and its partner BioNTech to apply for authorization of extra-low doses of its vaccine for the youngest children before clinical studies were finished. On Friday, the FDA reversed course.
Nation Feb 01 Pfizer asks FDA to allow COVID-19 vaccine for children under 5 Pfizer on Tuesday asked the U.S. to authorize extra-low doses of its COVID-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March.
Health Jan 31 Moderna’s COVID-19 vaccine wins full U.S. approval U.S. health regulators have given full approval to Moderna's COVID-19 vaccine after reviewing additional data on its safety and effectiveness.